What are Cancer-Causing Genetic Mutations and What Do They Mean to Me?
November 21, 2022
Understanding the resources available to you after a cancer diagnosis can help you with navigating your mental and physical health.
Genetics Info & Updates
BRCA Genes and Women’s Cancer Risk
September 23, 2022
By detecting BRCA gene mutations earlier in their lives, women with breast cancer cases can be treated more successfully.
Why Multiomics is Healthcare’s Next Big Step
September 21, 2022
Healthcare experts like Dr. Chris Hancock are leveraging multiomics to take a proactive approach to detecting diseases sooner.
HALO Diagnostics, IncellDx Partner to Advance Novel Testing, Improve Standard of Care for Prostate and Bladder Cancers
June 29, 2022
The precision diagnostics leader and molecular diagnostics company are joining forces to develop new, innovative testing for urogenital cancers that will improve the standard of care.
HALO Diagnostics and Genomic Testing Cooperative Partner to Advance Early Cancer Detection and Precision Diagnostics
June 14, 2022
The companies have come together to provide personalized testing that expands the possibilities of early cancer detection and precision diagnostics.
Protein Plays “Active Role” in Prostate Cancer Progression
November 1, 2021
A new study may kickstart new prostate cancer therapies, especially for more aggressive forms of the disease. Prostate cancer is a leading cause of death in men worldwide. When patients stop responding to traditional therapies, they often fight an uphill battle against an aggressive form of the disease. Findings from
Prostate Cancer Blood Testing Predicts Mortality Among African American Men
October 29, 2021
African American men are 60% more likely to develop prostate cancer than Caucasian men. Now, a new study may help assess their risk. Researchers say two proteins found in the blood of African American men can predict the likelihood of dying of prostate cancer. A study measured 82 different biomarkers
New PSMA PET Aid at HALO Dx Helps Diagnose Prostate Cancer
September 22, 2021
Almost 20 years in the making, researchers say PYLARIFY® is a triumph for the field of molecular and diagnostic imaging. Another groundbreaking prostate cancer imaging tool is now available at HALO Diagnostics. The tool is an injectable contrasting agent called PYLARIFY® that targets prostate-specific membrane antigen (PSMA), a protein found
How MRI & Genomics Could Prevent 1 in 6 Prostate Cancer Deaths
March 17, 2021
A new study suggests that screening for prostate cancer using genetic testing and a multiparametric MRI (mpMRI) scan before an invasive biopsy could prevent as many as 1 in 6 deaths from the disease and significantly reduce over-diagnosis and unnecessary treatment.[i] Researchers at the University College of London modeled the
Biomarkers and Genomics in Prostate Cancer Diagnostics and Treatment
September 24, 2020
Biomarker, genetic, and genomic testing offer men new insights into their prostate health and help choose the best course of action.
